Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,620,294
-$518,081 QoQ
Shares Held
67,288
-11.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1,053
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURKE & HERBERT BANK & TRUST CO holds $27,845,338 across 9 Drug Manufacturers - General names. PFE ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,190 | $9,953,084 | |
| 2 | LLY |
ELI LILLY & Co
|
5,231 | $6,274,217 | |
| 3 | ABBV |
AbbVie Inc.
|
20,061 | $5,048,149 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,309 | $2,609,706 | |
| 5 | PFE |
Pfizer Inc
This page
|
67,288 | $1,620,294 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,041 | $751,422 | |
| 7 | NVS |
Novartis AG
|
3,847 | $602,901 | |
| 8 | AMGN |
Amgen Inc
|
1,593 | $576,856 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,620,294 | 67,288 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,138,375 | 76,153 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,622,309 | 65,153 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,937,320 | 76,033 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,933,114 | 79,749 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,951,483 | 77,012 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,051,165 | 77,315 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,249,447 | 77,728 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,137,194 | 76,383 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,269,174 | 45,736 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,396,689 | 48,513 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,687,058 | 50,861 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,939,050 | 52,864 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $2,147,589 | 52,637 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,705,061 | 52,792 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $2,317,179 | 52,952 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,807,626 | 53,550 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $2,829,074 | 54,647 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,343,173 | 56,616 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $2,445,591 | 56,861 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,233,529 | 57,036 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,080,615 | 57,428 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,565,398 | 69,693 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $2,608,302 | 71,071 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $2,276,608 | 69,621 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,273,698 | 69,660 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||